News
Our study reveals that the PD-1 receptor functions optimally as dimers driven by interactions within the transmembrane domain on the surface of T cells, contrary to the dogma that PD-1 is a monomer." ...
When PD-1 binds to its partner receptors on other cells, PD-L1 or PD-L2, it sends a signal to the T cell to paralyze its normal immune function. Block PD-1 Checkpoints, Shrink Tumors ...
Co-author Dr Kenji Chamoto, from Kyoto University, says, "PD-1 inhibition has a 'yin and yang' nature: it activates anti-tumor immunity but at the same time impedes B-cell immunity.
Much of our understanding of PD-1’s functions, like many proteins, comes from studies in mice, based on the assumption that rodent and human biology operate similarly. However, human and mouse PD-1 ...
T-cell activity is often suppressed by the immunosuppressive nature of the tumor microenvironment, contributing to the limited efficacy of many immunotherapeutic strategies. Treatment with peptides ...
Cover Caption: PD-1 deficiency enhances Treg cell pro-tumor function Lim et al. demonstrate that Treg cells deficient in PD-1 occupy key spatial niches within the TME, with regulatory subsets ...
Initial meeting of Scientific Advisory Board (SAB) convened to discuss the first-in-human phase 1a/1b clinical trial of ...
The first patient has been treated in a phase 1/2 trial of a Moderna cancer vaccine designed to generate antibodies against immune checkpoints PD-L1 and IDO1.
In 1992, graduate student Yasumasa Ishida discovered PD-1, ... L150, together with aromatic residues at positions 166 and 174, forms a unique surface structure with currently unknown function.
7mon
News Medical on MSNPD-1 deficiency reveals the impact of checkpoint inhibition on B cell function - MSNPD-1 deficiency reveals the impact of checkpoint inhibition on B cell function. 3mo.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results